ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #14,263Gold OA

Melanoma Management

Identifier (ISSN):2045-0885(Print)/2045-0893(Online)
•
Publisher:Future Medicine Ltd
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
1.1↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Melanoma Management

WoS Q4
02353.62023120240.720251.12026
Annual Impact Factor Metric
Current (2026):1.1
Scopus SJR & RankScopus Q3
0.398
#14,263

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
16

16 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
4articles/year
100% Gold OA•100% Original Research

Aims & Scope

Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.

Topics Covered (Recognized by AI)
MedicineBiology97.4%Genetics96.3%Cancer research92.7%Melanoma91.6%Internal medicine80.1%Cancer65.4%Immunology47.6%Oncology44.5%Pathology42.4%Surgery37.7%Immune system36.6%Immunotherapy35.1%Chemistry33.5%Biochemistry31.4%Radiology21.5%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ONCOLOGY

Q4
Rank299/333
IndexESCI
JCIESCI2026

ONCOLOGY

Q4
Rank298/333
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.1
Articles / Year1
Total Citations2
2025
IF0.7
Articles / Year14
Total Citations14
2024
IF1
Articles / Year7
Total Citations13
2023
IF3.6
Articles / Year4
Total Citations17
2022
IF—
Articles / Year4
Total Citations18

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,263Scopus Q3SCImago Profile
Scopus Coverage:2014-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.398

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.17

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,015 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations21
3-Year Documents15
Citable Documents15

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

DermatologyQ3
OncologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Melanoma Management (ISSN: 2045-0885) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Future Medicine Ltd in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 1.10, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.398 (Q3), an H-index of 16.

The journal enforces rigorous peer evaluation with an annual output of approximately 4 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,015 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Future Medicine Ltd
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f7f0c6bc-27f5-4937-b9ce-0def41204969
Database Updated: 2026-10-01